News

Filter

226 to 235 of 97566 results

FDA Focus: Recalling dangerous and defective drugs

FDA Focus: Recalling dangerous and defective drugs

08-01-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks at how…

DrugsPharmaceuticalRegulationUnited StatesUSA

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

ViiV’s Triumeq offers added benefit for treatment-naive adults with HIV, says IQWiG

08-01-2015

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG), which had already assessed a…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTriumeqViiV Healthcare

Biotech industry shatters key fundraising records in 2014

08-01-2015

The biotech industry shattered records for venture investment, IPOs (initial public offerings) and M&A…

BiotechnologyFinancialGlobalLicensing

Ph III trial for AbbVie’s elagolix meets endpoints

08-01-2015

US pharma major AbbVie and partner Neurocrine Biosciences have announced positive top-line results from…

AbbVieelagolixNeurocrine BiosciencesPharmaceuticalResearchWomen's Health

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

08-01-2015

Researchers at Northeastern University in Boston, MA, and NovoBiotic Pharmaceuticals have made a breakthrough…

Antibiotics and Infectious diseasesMicrobiologyNovoBiotic PharmaceuticalsPharmaceuticalResearchTeixobactin

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

08-01-2015

Life science research tool supplier Horizon Discovery Group has agreed to acquire Haplogen Genomics,…

BiotechnologyEvent horizonHaplogen GenomicsHorizon Discovery GroupMergers & Acquisitions

BIO urges US FDA to release guidance on biosimilars

BIO urges US FDA to release guidance on biosimilars

08-01-2015

The US trade group the Biotechnology Industry Organization (BIO) has called on the Food and Drug Administration…

BiosimilarsBiotechnologyRegulationUSA

Sandoz’ Neupogen biosimilar backed by FDA advisory panel

Sandoz’ Neupogen biosimilar backed by FDA advisory panel

08-01-2015

The US Food and Drug Administration Oncologic Drugs Advisory Committee (ODAC), in a unanimous vote, recommended…

AmgenBiosimilarsBiotechnologyFilgrastimNeupogenNovartisOncologyRegulationSandozUSAZarxio

226 to 235 of 97566 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top